Table 1.
Number of eyes enrolled (patients) | 20 (20) |
Age, years, mean ± SD | 59.3 ± 14.9 |
Gender | |
- M, n (%) | 15 (75%) |
- F, n (%) | 5 (25%) |
BCVA, Snellen equivalent, mean | 20/25 |
Level of DR, n | |
- Mild | 3 |
- Moderate | 11 |
- Severe | 3 |
- Proliferative | 3 |
Previous treatment, n | |
- Focal/grid laser | 2 |
- Panretinal laser | 6 |
- Anti-VEGF | 9 |
- Dexamethasone implant | 2 |
- Treatment naïve | 5 |
M: males; F: females; n: number of eyes; BCVA: best corrected visual acuity; VEGF: vascular endothelial growth factor.